| # | Drug | Count |
|---|---|---|
| 0 | ZIDOVUDINE | 168 |
| 1 | NEVIRAPINE | 124 |
| 2 | LAMIVUDINE | 119 |
| 3 | LAMIVUDINE ORAL | 118 |
| 4 | EFAVIRENZ | 33 |
| 5 | RILPIVIRINE | 26 |
| 6 | CABOTEGRAVIR | 24 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE | 22 |
| 8 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 22 |
| 9 | LOPINAVIR AND RITONAVIR | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ZIDOVUDINE | 168 | 0.0162 |
| 1 | NEVIRAPINE | 124 | 0.0138 |
| 2 | FOSTEMSAVIR TROMETHAMINE | 3 | 0.0123 |
| 3 | LAMIVUDINE | 119 | 0.0047 |
| 4 | DORAVIRINE | 3 | 0.0038 |
| 5 | RILPIVIRINE | 26 | 0.0036 |
| 6 | EFAVIRENZ | 33 | 0.0030 |
| 7 | CABOTEGRAVIR | 24 | 0.0029 |
| 8 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 22 | 0.0025 |
| 9 | LENACAPAVIR SODIUM | 1 | 0.0020 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 147 | 0.0061 |
| 1 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 121 | 0.0025 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 195 | 0.0018 |
| 3 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 4 | Protease Inhibitor [EPC] | 23 | 0.0005 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 24 | 0.0004 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 8 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 9 | 5-alpha Reductase Inhibitor [EPC] | 1 | 0.0000 |